Login     Register  
    Home  |   Privacy & Security  |   Search  |   About Us  |   Contact Us  |   Disclaimer
BioOntario - Ag Biotech,  Biotechnology and Pharmaceutical Portal for Ontario Canada CAR-T therapy is set to revolutionize oncology pipelines and mark a new era for personalized medicine. With the recent approvals of Yescarta and Kymriah and the $11 billion acquisition of Kite, the race is on to lead the commercialization of safe, efficacious and accessible CAR-T therapy.
The fourth annual CAR-T congress USA is bringing together the leading pharmaceutical companies, the disruptive biotechs and pioneering academic institutions to assess emerging novel data and tackle the current challenges including antigen discovery, manufacturing scalability and efficacy.
Site Search:
    Home Innovation Community Patient Engagement News Events
 Pub Med Central Search   Close Portlet and Return to previous page
Search PMC Journals:


Search Tips

Using the Site Privacy & Security Statement Advertise with us Event Postings CanBiotech Newsletters

© 2000-2019 CanBiotech™ Inc.